RESEARCH-USE BIOSIMILAR ANTIBODY

Ormutivimab Biosimilar Antibody

Monoclonal antibody · IgG1

Target: Rabies Virus Surface Glycoprotein 4 (gp4) Epitope 1IgG1RUO

SC-BS-304 is a research-use monoclonal antibody associated with the Ormutivimab reference molecule and the recorded target Rabies Virus Surface Glycoprotein 4 (gp4) Epitope 1.

Reference molecule
Ormutivimab
Catalog number
SC-BS-304
Format
Monoclonal antibody
Expression host
Mammalian cells (CHO or HEK293)
RESEARCH PLANNING

Built for configurable research workflows

Review specifications →
01Research use onlyFor analytical, binding and assay-development research
02Configurable supplyFour pack sizes with optional custom conjugation
03Document supportConfiguration- and lot-specific documents upon inquiry

PRODUCT OVERVIEW

Defined product identity with explicit evidence boundaries

SC-BS-304 is a research-use monoclonal antibody associated with the Ormutivimab reference molecule and the recorded target Rabies Virus Surface Glycoprotein 4 (gp4) Epitope 1.

This page supports comparative binding, assay-development and analytical research planning. Product-specific affinity, epitope, functional activity and therapeutic equivalence are not claimed unless supported by separately released documentation.

01

Defined reference context

Ormutivimab molecule context with Rabies Virus Surface Glycoprotein 4 (gp4) Epitope 1 as the recorded target.

02

Configurable research supply

4 inquiry pack-sizes with optional custom conjugation and availability confirmed by quotation.

03

Transparent evidence boundary

Reference-molecule and target context are separated from product-specific and lot-specific evidence.

RELATED TOOLS

Controls, target protein, detection and custom labeling

RELATED BIOSIMILAR ANTIBODIES

Direct product links support comparison, discovery and catalog navigation.
Compare additional products by name, target, format, isotype or species.Browse all biosimilar antibodies
SC-BS-304-100UG100 µg · UnconjugatedRequest quote
开启沟通

告诉我们你的研究目标。

询价、样品申请或技术咨询,我们会从具体靶点与实验场景开始沟通。

联系我们
Ormutivimab Biosimilar Antibody | SC-BS-304